Michael Schmitt

29PUBLICATIONS
83CO-AUTHORS
NanomedicineCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Molecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Aug 03, 2026
Author Correction: IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial.

|Jul 29, 2026
A distinct CAR-T cell phenotype mediates therapeutic response at limited doses.

|Jul 01, 2026
IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial.

|Oct 02, 2025
Integrated scFv identification and CAR T cell generation for AML targeting in vivo.

Yi Liu, Annika Lauk, David Sedloev

|Sep 27, 2025
First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid Neoplasms.

Simone Thomas, Martin Wermke, Vladan Vučinić

|Aug 27, 2024
Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia: a phase 1/2 study.

Patrick Derigs, Maria-Luisa Schubert, Peter Dreger

Pageof 5

Frequent Collaborators

5 joint publications

Leopold Sellner

4 joint publications

Carsten Müller-Tidow

4 joint publications

Michael Platten

4 joint publications

Lukas Bunse